Lebwohl M - Search Results

1

Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.

Lebwohl M, Menter A, Weiss J, Clark SD, Flores J, Powers J, Balin AK, Kempers S, Glinert RJ, Fleming T, Liu Y, Graeber M, Pariser DM. Lebwohl M, et al. J Drugs Dermatol. 2007 Apr;6(4):428-35. J Drugs Dermatol. 2007. PMID: 17668541 Clinical Trial.

2

Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalis.

Lebwohl M, Sacks S, Conant M, Connor J, Douglas JM Jr, Eron L, Marlowe S, Mendelson J, Chen V, Bradstreet P, et al. Lebwohl M, et al. Antiviral Res. 1992 Mar;17(3):235-43. doi: 10.1016/0166-3542(92)90044-6. Antiviral Res. 1992. PMID: 1567188 Clinical Trial.

3

A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis.

Olsen EA, Cram DL, Ellis CN, Hickman JG, Jacobson C, Jenkins EE, Lasser AE, Lebwohl M, Leibsohn E, Medansky RS, et al. Olsen EA, et al. Among authors: lebwohl m. J Am Acad Dermatol. 1991 Mar;24(3):443-7. doi: 10.1016/0190-9622(91)70069-e. J Am Acad Dermatol. 1991. PMID: 2061442 Clinical Trial.

4

Effects of topical preparations on the erythemogenicity of UVB: implications for psoriasis phototherapy.

Lebwohl M, Martinez J, Weber P, DeLuca R. Lebwohl M, et al. J Am Acad Dermatol. 1995 Mar;32(3):469-71. doi: 10.1016/0190-9622(95)90071-3. J Am Acad Dermatol. 1995. PMID: 7868718

5

Pemphigus vulgaris after initiation of psoralen and UVA therapy for psoriasis.

Fryer EJ, Lebwohl M. Fryer EJ, et al. Among authors: lebwohl m. J Am Acad Dermatol. 1994 Apr;30(4):651-3. doi: 10.1016/s0190-9622(09)80116-3. J Am Acad Dermatol. 1994. PMID: 8157795 No abstract available.

6

Topical therapy for psoriasis.

Lebwohl M, Abel E, Zanolli M, Koo J, Drake L. Lebwohl M, et al. Int J Dermatol. 1995 Oct;34(10):673-84. Int J Dermatol. 1995. PMID: 8537153 Review. No abstract available.

7

Efficacy and safety of fluticasone propionate ointment, 0.005%, in the treatment of eczema.

Lebwohl M. Lebwohl M. Cutis. 1996 Feb;57(2 Suppl):62-8. Cutis. 1996. PMID: 8646873 Clinical Trial.

8

A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis.

Lebwohl M, Siskin SB, Epinette W, Breneman D, Funicella T, Kalb R, Moore J. Lebwohl M, et al. J Am Acad Dermatol. 1996 Aug;35(2 Pt 1):268-9. doi: 10.1016/s0190-9622(96)90349-7. J Am Acad Dermatol. 1996. PMID: 8708035 Clinical Trial. No abstract available.

9

Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled study.

Pariser DM, Pariser RJ, Breneman D, Lebwohl M, Kalb R, Moore J, Moss H, Parker C, Fiedler V. Pariser DM, et al. Among authors: lebwohl m. Arch Dermatol. 1996 Dec;132(12):1527. Arch Dermatol. 1996. PMID: 8961897 Clinical Trial. No abstract available.

10

Topical calcipotriene in combination with UVB phototherapy for psoriasis.

Hecker D, Lebwohl M. Hecker D, et al. Among authors: lebwohl m. Int J Dermatol. 1997 Apr;36(4):302-3. doi: 10.1046/j.1365-4362.1997.00203.x. Int J Dermatol. 1997. PMID: 9169336 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

751 results

Search Page

Filters